Accelerate the implementation of new vaccine manufacturing technologies across multiple platform processes by addressing workforce and technology issues that U.S. and global vaccine manufacturers and suppliers face and establishing a Center of Excellence for Vaccine Analytics and Assays.
Accelerate the production of innovative vaccines by ensuring that both U.S.-based and global vaccine manufacturers and suppliers have adequate support to implement advanced manufacturing and product characterization processes.
Objective: Develop a facility and equipment available for NIIMBL members to assess techniques and facilitate training and knowledge sharing
Objective: Evaluate next-generation sequencing (NGS) as a rapid alternative assay for in vivo and in vitro adventitious virus testing for vaccine safety
Associate Institute Director
NIIMBL Senior Fellow
Scientific Program Manager
The program focuses on five key areas — standardization and contextualization, end-to-end automated control of critical quality attributes (CQAs), multivariate sensors and analytics, advanced control strategies, and bioprocess modeling and simulation – that will enable biomanufacturers to harness the power of data for real-time decision-making.
Access more program information, including:
Learn more about how being a member of NIIMBL can grant you and your company access to NIIMBL-led programs and other collaboration opportunities.